Maravai LifeSciences Holdings, Inc. (MRVI) Total liabilities 2020–2025
Maravai LifeSciences Holdings, Inc. (MRVI) total liabilities at each fiscal year-end, per SEC filings.
$397.9MFY2025 · since FY2020: $1.1B → $397.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $397.9M | -7.7% |
| FY2024 | $431.0M | -38.2% |
| FY2023 | $697.6M | -49.3% |
| FY2022 | $1.4B | +0.3% |
| FY2021 | $1.4B | +23.0% |
| FY2020 | $1.1B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice